HQH (abrdn Healthcare Investors) Moat Score: 3/10 (As of Jul. 08, 2026)


HQH abrdn Healthcare Investors HQH
48 GF Score
Price $21.87
GF Value $50.26
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is abrdn Healthcare Investors Moat Score?

abrdn Healthcare Investors HQH -1.00% 48 Moat Score is 3 as of Jul. 08, 2026. GuruFocus rates HQH with a GF Score™ of 48/100 and a GF Value™ of $50.26 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 1,698 Asset Management companies, abrdn Healthcare Investors ranks better than 90.69% on this metric.

abrdn Healthcare Investors has the Moat Score of 3, which implies that the company might have No Moat - Very weak/transient advantages.

abrdn Healthcare Investors has No Moat: abrdn Healthcare Investors lacks significant competitive advantages. It operates in a competitive investment management industry with low switching costs and limited brand strength, resulting in a very weak moat.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes abrdn Healthcare Investors might have No Moat - Very weak/transient advantages.

abrdn Healthcare Investors  (NYSE:HQH) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

abrdn Healthcare Investors Moat Score Related Terms

HQH vs DSL, NMZ, JFR: Moat Score Comparison

For the Asset Management subindustry, abrdn Healthcare Investors's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

abrdn Healthcare Investors Moat Score vs Asset Management Industry

For the Asset Management industry and Financial Services sector, abrdn Healthcare Investors's Moat Score distribution charts can be found below:

* The bar in red indicates where abrdn Healthcare Investors's Moat Score falls into.


HQH
48GF Score
abrdn Healthcare Investors HQH
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 3 mean?
abrdn Healthcare Investors (HQH) has a Moat Score of 3 as of Jul. 08, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, abrdn Healthcare Investors ranks #158 out of 1698 companies in the Asset Management industry, placing it in the top 9.3%.
Is abrdn Healthcare Investors' Moat Score too high?
abrdn Healthcare Investors' current Moat Score is 3. Based on the distribution chart, abrdn Healthcare Investors ranks #158 out of 1698 companies in the Asset Management industry, which is in the top quartile — a strong position relative to peers. Overall, abrdn Healthcare Investors has a GF Score™ of 48/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does abrdn Healthcare Investors' Moat Score compare to DSL and NMZ?
According to the Asset Management industry distribution chart, abrdn Healthcare Investors ranks #158 out of 1698 companies for Moat Score. This places abrdn Healthcare Investors in the top 9% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for an Asset Management company?
A good Moat Score depends on the Asset Management industry context. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. abrdn Healthcare Investors's current Moat Score is 3. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is abrdn Healthcare Investors stock overvalued right now?
Based on GuruFocus' analysis, abrdn Healthcare Investors (HQH) is currently considered Possible Value Trap. The stock's GF Value™ is $50.26, compared to a current price of $21.87 — trading 56.5% below its estimated fair value. The current Moat Score is 3. abrdn Healthcare Investors' overall GF Score™ is 48/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For abrdn Healthcare Investors (HQH), the current Moat Score is 3 as of Jul. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is abrdn Healthcare Investors (HQH) Overvalued in 2026?

Based on GuruFocus' analysis, abrdn Healthcare Investors stock appears to be undervalued. The current stock price of $21.87 is trading 56.5% below its estimated GF Value™ of $50.26. GuruFocus considers abrdn Healthcare Investors to be Possible Value Trap.

Key valuation signals for HQH:

  • Moat Score: 3
  • GF Value™: $50.26 vs. price of $21.87 (56.5% below fair value)
  • GF Score™: 48/100 with 6 warning signs

No single metric tells the full story. See the HQH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

abrdn Healthcare Investors Business Description

Address 1900 Market Street, Suite 200, Philadelphia, PA, USA, 19103
abrdn Healthcare Investors Formerly Tekla Healthcare Investors is the United States based non-diversified closed-end management investment company. Its objective is to seek long-term capital appreciation by investing in securities of healthcare companies. In addition, the fund seeks to provide regular distribution of realized capital gains. The fund invests in the securities of public and private companies.
48GF Score

Get the complete analysis for HQH

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$21.87
Price
$50.26
GF Value